Verition Fund Management
CLB icon

Verition Fund Management’s Core Laboratories CLB Stock Holding History

Verition Fund Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-31,719
Closed -$365K – 3783
2025
Q2 		$365K Buy
31,719
+20,233
+176% +$240K ﹤0.01% 3107
2025
Q1 		$172K Sell
11,486
-28,065
-71% -$470K ﹤0.01% 3080
2024
Q4 		$685K Buy
39,551
+25,279
+177% +$488K ﹤0.01% 2284
2024
Q3 		$264K Sell
14,272
-4,795
-25% -$96.3K ﹤0.01% 2720
2024
Q2 		$387K Buy
+19,067
New +$337K ﹤0.01% 2200
2019
Q3 		– Sell
-20,165
Closed -$1.05M – 1076
2019
Q2 		$1.05M Buy
+20,165
New +$1.18M 0.03% 421
2014
Q1 		– Sell
-1,367
Closed -$261K – 514
2013
Q4 		$261K Buy
+1,367
New +$254K 0.05% 310

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Verition Fund Management's CLB Position: Q3 2025 in Review

Verition Fund Management sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 31,719 shares — an estimated $365K sold.

Verition Fund Management first reported a position in CLB in Q4 2013 and held it in 7 quarters. The position peaked at $1.05M in Q2 2019. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

  • Verition Fund Management reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
  • Verition Fund Management sold 31,719 Core Laboratories shares in Q3 2025, an estimated $365K.
  • Verition Fund Management first reported a position in Core Laboratories in Q4 2013 and held it in 7 quarters.
  • Verition Fund Management's Core Laboratories position peaked at $1.05M in Q2 2019.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.